SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-21-092796
Filing Date
2021-07-16
Accepted
2021-07-16 06:01:29
Documents
4
Period of Report
2021-07-15
Items
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2122365d1_8k.htm 8-K 23370
2 EXHIBIT 99.1 tm2122365d1_ex99-1.htm EX-99.1 10614
3 EXHIBIT 99.2 tm2122365d1_ex99-2.htm EX-99.2 1800
4 GRAPHIC image_001.jpg GRAPHIC 80879
  Complete submission text file 0001104659-21-092796.txt   148614
Mailing Address 600 MADISON AVENUE, SUITE 1601 NEW YORK NY 10022-1737
Business Address 600 MADISON AVENUE, SUITE 1601 NEW YORK NY 10022-1737 302 355-0650
iBio, Inc. (Filer) CIK: 0001420720 (see all company filings)

IRS No.: 262797813 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 001-35023 | Film No.: 211094211
SIC: 2834 Pharmaceutical Preparations